Precision medicine in type 1 diabetes: comparing metabolic outcomes of Control-IQ and MiniMed 780G according to patient characteristics.

Diabetes Obes Metab · 2025 · PMC11802389 · PMID 39690388

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

close to significanceno p-value reported

automated insulin delivery carbohydrate counting precision medicine type 1 diabetes Clinical Research Department of the Sud‐Francilien Hospital Subgroup analysis showed consistent results across subgroups of patient baseline characteristics, albeit overall interaction was close to significance for sex, age and baseline daily dose of insulin (overall p interaction of 0.16, 0.16 and 0.15 respectively).

also in 2,130 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.